End-of-day quote
Shanghai S.E.
18:00:00 2024-07-01 EDT
|
5-day change
|
1st Jan Change
|
31.07
CNY
|
-1.52%
|
|
-0.99%
|
+8.56%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
20,590
|
37,205
|
23,789
|
21,051
|
21,594
|
23,442
|
-
|
-
|
Enterprise Value (EV)
1 |
20,590
|
37,205
|
23,789
|
21,051
|
21,594
|
23,442
|
23,442
|
23,442
|
P/E ratio
|
13
x
|
26.9
x
|
13.6
x
|
10.7
x
|
10.1
x
|
9.77
x
|
8.95
x
|
8.04
x
|
Yield
|
2.34%
|
1.12%
|
2.22%
|
2.8%
|
2.98%
|
3.06%
|
3.28%
|
3.6%
|
Capitalization / Revenue
|
0.46
x
|
0.92
x
|
0.51
x
|
0.46
x
|
0.43
x
|
0.44
x
|
0.4
x
|
0.36
x
|
EV / Revenue
|
0.46
x
|
0.92
x
|
0.51
x
|
0.46
x
|
0.43
x
|
0.44
x
|
0.4
x
|
0.36
x
|
EV / EBITDA
|
8.11
x
|
18.4
x
|
9.31
x
|
7.5
x
|
7.04
x
|
8.34
x
|
7.31
x
|
6.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.95
x
|
3.25
x
|
1.86
x
|
1.48
x
|
1.37
x
|
1.37
x
|
1.22
x
|
1.1
x
|
Nbr of stocks (in thousands)
|
754,503
|
754,503
|
754,503
|
754,503
|
754,503
|
754,503
|
-
|
-
|
Reference price
2 |
27.29
|
49.31
|
31.53
|
27.90
|
28.62
|
31.07
|
31.07
|
31.07
|
Announcement Date
|
3/27/20
|
3/18/21
|
3/16/22
|
3/22/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
44,644
|
40,379
|
46,469
|
45,499
|
49,696
|
53,361
|
59,068
|
65,201
|
EBITDA
1 |
2,539
|
2,022
|
2,554
|
2,807
|
3,066
|
2,810
|
3,208
|
3,720
|
EBIT
1 |
2,436
|
1,913
|
2,447
|
2,695
|
2,944
|
3,286
|
3,580
|
3,984
|
Operating Margin
|
5.46%
|
4.74%
|
5.27%
|
5.92%
|
5.92%
|
6.16%
|
6.06%
|
6.11%
|
Earnings before Tax (EBT)
1 |
2,427
|
1,917
|
2,445
|
2,688
|
2,931
|
3,273
|
3,568
|
3,972
|
Net income
1 |
1,604
|
1,383
|
1,754
|
1,964
|
2,146
|
2,396
|
2,617
|
2,916
|
Net margin
|
3.59%
|
3.42%
|
3.77%
|
4.32%
|
4.32%
|
4.49%
|
4.43%
|
4.47%
|
EPS
2 |
2.105
|
1.833
|
2.325
|
2.603
|
2.844
|
3.180
|
3.470
|
3.865
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.6380
|
0.5500
|
0.7000
|
0.7820
|
0.8540
|
0.9500
|
1.020
|
1.120
|
Announcement Date
|
3/27/20
|
3/18/21
|
3/16/22
|
3/22/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
13,166
|
12,122
|
14,076
|
13,505
|
14,351
|
13,338
|
15,343
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
477.7
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.6332
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/24/23
|
3/20/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
16.3%
|
12.7%
|
14.6%
|
14.7%
|
13.7%
|
14.4%
|
14%
|
13.8%
|
ROA (Net income/ Total Assets)
|
7.02%
|
5.63%
|
6.7%
|
6.82%
|
6.92%
|
6.93%
|
7.03%
|
7%
|
Assets
1 |
22,851
|
24,551
|
26,190
|
28,809
|
31,031
|
34,558
|
37,209
|
41,664
|
Book Value Per Share
2 |
14.00
|
15.20
|
16.90
|
18.80
|
20.90
|
22.70
|
25.40
|
28.30
|
Cash Flow per Share
2 |
2.350
|
1.730
|
2.590
|
3.170
|
3.610
|
2.280
|
3.050
|
3.740
|
Capex
1 |
84.8
|
67.8
|
94.3
|
126
|
145
|
168
|
134
|
86
|
Capex / Sales
|
0.19%
|
0.17%
|
0.2%
|
0.28%
|
0.29%
|
0.31%
|
0.23%
|
0.13%
|
Announcement Date
|
3/27/20
|
3/18/21
|
3/16/22
|
3/22/23
|
3/20/24
|
-
|
-
|
-
|
Last Close Price
31.07
CNY Average target price
44.3
CNY Spread / Average Target +42.58% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.56% | 3.22B | | +26.32% | 75.86B | | -4.23% | 23.51B | | +15.24% | 8.76B | | +1.47% | 8.31B | | -33.21% | 6.66B | | +18.99% | 5.45B | | +1.72% | 4.05B | | -8.73% | 3.8B | | -9.28% | 3.33B |
Pharmaceuticals Wholesale
|